|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | The U.S. House Rules Committee did not include the BIOSECURE Act in the final list of amendments for the National Defense Authorization Act (NDAA). Chief Editor Louis Garguilo has been outspoken in defending WuXi Apptec’s right to due process. Readers have responded in spades. Here's the latest. |
|
|
|
Don't Blame The Molecule; You May Be The Problem | By Louis Garguilo, Chief Editor, Outsourced Pharma | Ali Pashazadeh has been a healthcare investment banker for 20 years, surgeon for 30, and biotech CEO. Today he leads Treehill Partners. “I can explain our logic in two minutes,” he says of his approach to developing drugs, and targeting diseases. |
|
|
|
|
|
|
|
|
|
|
HLA Testing: Comprehensive Genotyping For Human Leukocyte Antigen | Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises | HLA testing is a crucial component of advanced therapeutics. Learn how leveraging a cell therapy-focused CDMO enables a true end-to-end solution and accelerates treatment timelines for patients in need. |
|
|
Gene Therapy, Oncolytic Viruses, Viral Vaccines CDMO Services | FUJIFILM Diosynth Biotechnologies | Our gene therapy viral vector process development and manufacturing capabilities are designed to confidently and rapidly progress your products from gene to market through development of robust and reproducible cGMP practices. |
|
|
GMP-Compliant Production Lines Of Plasmid | OBiO Tech | The OBiO Intelli-M GMP manufacturing site has three production lines of prokaryotic cell culture plasmid for commercial manufacturing, including a single-use whole process production line and two stainless steel production lines. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
